Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FCI Ophthalmics is a private ophthalmic medical device company focused on surgical and non-surgical products for eye care professionals. The company operates as the U.S. branch of FCI and markets a broad portfolio spanning lacrimal stents and tubes, eyelid implants and weights, orbital implants, dry eye devices, cataract surgery devices, and vitreoretinal products. Its business is centered on commercialized ophthalmic devices rather than a drug-development pipeline, with particular strengths in oculoplastics, lacrimal surgery, dry eye management, cataract, and retina. FCI also offers surgical training products such as KITARO lab kits and works with ophthalmic surgeons to develop and refine device solutions. The company serves physicians and surgeons across the United States from Pembroke, Massachusetts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FCI Ophthalmics.